Atlas Trials

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

Clinical trial NCT01852682 · COMPLETED

Trial details

NCT number
NCT01852682
Sponsor
Kissei Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Peritoneal DialysisHyperphosphatemia
Primary completion
2014-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.